ArticleProceedings of the National Academy of Sciences of the United States of America2025

Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive.

Monica B Kirby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.